Frequency Exchange (FREQ) 주식 개요는 건강 및 웰니스 시장을 위한 웨어러블 주파수 전달 시스템의 개발 및 상용화에 주력하고 있습니다. 자세히 보기FREQ 펀더멘털 분석스노우플레이크 점수가치 평가0/6미래 성장0/6과거 실적0/6재무 건전성4/6배당0/6위험 분석수익이 USD$1m 미만입니다(CA$745K)cash runway 경력이 1년 미만입니다.지난 3개월 동안 주가 변동성이 Canadian 시장과 비교했을 때 매우 높았습니다.의미 있는 시가총액이 없습니다(CA$15M)+ 위험 1건 추가모든 위험 점검 보기FREQ Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueCA$Current PriceCA$0.262.3k% 고평가 내재 할인율Est. Revenue$PastFuture-4m1m2016201920222025202620282031Revenue CA$745.1kEarnings CA$96.4kAdvancedSet Fair ValueView all narrativesFrequency Exchange Corp. 경쟁사Aurora SpineSymbol: TSXV:ASGMarket cap: CA$18.0mNanalysis ScientificSymbol: TSXV:NSCIMarket cap: CA$16.6mMedX HealthSymbol: TSXV:MDXMarket cap: CA$16.4mConavi MedicalSymbol: TSXV:CNVIMarket cap: CA$23.3m가격 이력 및 성과Frequency Exchange 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가CA$0.2652주 최고가CA$0.3852주 최저가CA$0.20베타0.111개월 변동-18.75%3개월 변동-3.70%1년 변동4.00%3년 변동300.00%5년 변동n/aIPO 이후 변동-35.00%최근 뉴스 및 업데이트New Risk • Jun 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: CA$13.6m (US$9.56m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.4m free cash flow). Share price has been highly volatile over the past 3 months (25% average weekly change). Revenue is less than US$1m (CA$745k revenue, or US$526k). Market cap is less than US$10m (CA$13.6m market cap, or US$9.56m). Minor Risk Shareholders have been diluted in the past year (22% increase in shares outstanding).New Risk • Apr 26New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.2m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.2m free cash flow). Share price has been highly volatile over the past 3 months (30% average weekly change). Revenue is less than US$1m (CA$886k revenue, or US$649k). Minor Risks Shareholders have been diluted in the past year (22% increase in shares outstanding). Market cap is less than US$100m (CA$16.3m market cap, or US$11.9m).공시 • Apr 21Frequency Exchange Corp., Annual General Meeting, Jun 16, 2026Frequency Exchange Corp., Annual General Meeting, Jun 16, 2026. Location: british columbia, vancouver CanadaNew Risk • Feb 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: CA$11.6m (US$8.56m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Revenue is less than US$1m (CA$1.1m revenue, or US$828k). Market cap is less than US$10m (CA$11.6m market cap, or US$8.56m). Minor Risk Shareholders have been diluted in the past year (23% increase in shares outstanding).Board Change • Jan 02High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. Chairman, President & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Dec 20Frequency Exchange Corp. Announces the Appointment of Sammy Chow to Its Advisory BoardFrequency Exchange Corp. announced the appointment of Sammy Chow to its Advisory Board. Sammy Chow brings more than two decades of leadership experience in finance, operations, corporate development, and strategy. He has held senior executive roles including Chief Financial Officer and Chief Operating Officer across sectors such as manufacturing, technology, and renewable energy. Mr. Chow has worked with both startups and global organizations, including Fortune 500 companies, across Asia, the United States, and Canada. He has led and supported initiatives involving capital investments, market entry, and strategic partnerships resulting in more than $1 billion in successful transactions. Sammy adds valuable capital markets and operational depth to leadership group. Sammy holds an MBA from the University of Ottawa, a Bachelor of Commerce from the University of British Columbia, and is a Chartered Financial Analyst (CFA).더 많은 업데이트 보기Recent updatesNew Risk • Jun 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: CA$13.6m (US$9.56m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.4m free cash flow). Share price has been highly volatile over the past 3 months (25% average weekly change). Revenue is less than US$1m (CA$745k revenue, or US$526k). Market cap is less than US$10m (CA$13.6m market cap, or US$9.56m). Minor Risk Shareholders have been diluted in the past year (22% increase in shares outstanding).New Risk • Apr 26New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.2m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.2m free cash flow). Share price has been highly volatile over the past 3 months (30% average weekly change). Revenue is less than US$1m (CA$886k revenue, or US$649k). Minor Risks Shareholders have been diluted in the past year (22% increase in shares outstanding). Market cap is less than US$100m (CA$16.3m market cap, or US$11.9m).공시 • Apr 21Frequency Exchange Corp., Annual General Meeting, Jun 16, 2026Frequency Exchange Corp., Annual General Meeting, Jun 16, 2026. Location: british columbia, vancouver CanadaNew Risk • Feb 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: CA$11.6m (US$8.56m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Revenue is less than US$1m (CA$1.1m revenue, or US$828k). Market cap is less than US$10m (CA$11.6m market cap, or US$8.56m). Minor Risk Shareholders have been diluted in the past year (23% increase in shares outstanding).Board Change • Jan 02High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. Chairman, President & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Dec 20Frequency Exchange Corp. Announces the Appointment of Sammy Chow to Its Advisory BoardFrequency Exchange Corp. announced the appointment of Sammy Chow to its Advisory Board. Sammy Chow brings more than two decades of leadership experience in finance, operations, corporate development, and strategy. He has held senior executive roles including Chief Financial Officer and Chief Operating Officer across sectors such as manufacturing, technology, and renewable energy. Mr. Chow has worked with both startups and global organizations, including Fortune 500 companies, across Asia, the United States, and Canada. He has led and supported initiatives involving capital investments, market entry, and strategic partnerships resulting in more than $1 billion in successful transactions. Sammy adds valuable capital markets and operational depth to leadership group. Sammy holds an MBA from the University of Ottawa, a Bachelor of Commerce from the University of British Columbia, and is a Chartered Financial Analyst (CFA).공시 • Dec 18Frequency Exchange Corp. Announces the Appointment of Gail Edgell to Its Advisory BoardFrequency Exchange Corp. announced the appointment of Gail Edgell to its Advisory Board. Gail Edgell brings over 25 years of experience in the wellness industry, with leadership roles across corporate wellness, professional supplements, biotechnology startups, and integrative clinical consulting. She has held strategic positions focused on market development, practitioner engagement, and education-based commercialization, contributing to consistent revenue growth across several companies. Her career includes senior contributions at Designs for Health, where she helped scale practitioner channel sales from $360,000 to $1.5 million in under three years, and at Bio-Botanical Research, where she launched a practitioner partnership model that reached $1 million in annualized revenue within 90 days. Ms. Edgell has also supported business development efforts at Panaceutics Nutrition, a biotech startup, and has advised numerous integrative health clinics on operational growth and patient education strategies. Ms. Edgell is also a published author, founder of Inside Out Wellness, and a former nonprofit executive who led wellness-focused programs serving over 300 organizations and communities. She continues to collaborate with leading nutrition companies and healthcare educators to reimagine practitioner support experiences.공시 • Dec 15Frequency Exchange Corp Appoints Michael Moe To Advisory BoardFrequency Exchange Corp. has appointed Michael Moe to its Advisory Board. Michael Moe is the Founder and CEO of GSV. He is also the co-founder of the ASU+GSV Summit, which Forbes referred to as the Davos of Education, and has contributed to expanding global interest in the digital learning and wellness sectors through GSV's various funds and partnerships. Mr. Moe previously served as Head of Global Growth Research at Merrill Lynch and was named to the Institutional Investor All-America Research Team. He also founded ThinkEquity Partners and has authored several books on entrepreneurship and impact-focused investing. Michael holds a BA in Political Science and Economics from the University of Minnesota and is a CFA charterholder.Reported Earnings • Nov 21Third quarter 2025 earnings released: CA$0.016 loss per share (vs CA$0.005 loss in 3Q 2024)Third quarter 2025 results: CA$0.016 loss per share (further deteriorated from CA$0.005 loss in 3Q 2024). Revenue: CA$170.0k (down 23% from 3Q 2024). Net loss: CA$796.0k (loss widened 256% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.공시 • Sep 25Frequency Exchange Corp. announced that it has received CAD 1.838034 million in fundingOn September 24, 2025, Frequency Exchange Corp. closed the transaction. The company issued an additional 3,418,031 units at a price of CAD 0.25 per unit for proceeds of CAD 854,507.75 in second and final tranche, bringing the total private placement to 7,352,133 units for aggregated proceeds of CAD 1,838,033.25 when combined with the first-tranche closing. Each unit consisted of one common share and one common share purchase warrant having an exercise price of CAD 0.40 per warrant and a term of 24 months from the date of issuance. The company issued 72,800 non-transferable finder warrants and paid a cash commission of CAD 18,200 to Canaccord Genuity Corp. The finder warrants are at an exercise price of CAD 0.40 per share for a period of 24 months from the date of issuance and are subject to the same acceleration clause as the warrants. All securities issued in connection with the second tranche of the private placement are subject to a statutory hold period expiring January 25, 2026.New Risk • Sep 25New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 15% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CA$689k). Revenue is less than US$1m (CA$1.2m revenue, or US$845k). Minor Risks Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (CA$17.5m market cap, or US$12.6m).New Risk • Aug 28New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 15% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$689k). Revenue is less than US$1m (CA$1.2m revenue, or US$852k). Minor Risks Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (CA$18.4m market cap, or US$13.3m).Reported Earnings • Aug 26Second quarter 2025 earnings released: CA$0.003 loss per share (vs CA$0.005 loss in 2Q 2024)Second quarter 2025 results: CA$0.003 loss per share (improved from CA$0.005 loss in 2Q 2024). Revenue: CA$250.2k (down 5.5% from 2Q 2024). Net loss: CA$122.0k (loss narrowed 45% from 2Q 2024). Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.공시 • Jul 22Frequency Exchange Corp. announced that it expects to receive CAD 1.5 million in fundingFrequency Exchange Corp. announced a private placement to issue 6,000,000 units at an issue price of CAD 0.25 per unit for gross proceeds of CAD 1,500,000 on July 21, 2025. Each unit is comprised of one common share and one common share purchase warrant having an exercise price of CAD 0.40 per warrant and a term of 24 months from the date of closing of the private placement. Finders’ fees of up to 8% cash and 8% finders’ warrants, having the same terms as the warrants, may be paid if applicable in respect of the private placement closing. The private placement is subject to TSX Venture Exchange approval, and all securities issued will be subject to a four-month hold period.Board Change • Jun 04High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. Chairman, President & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.New Risk • May 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$724k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$724k free cash flow). Shares are highly illiquid. Negative equity (-CA$623k). Revenue is less than US$1m (CA$1.2m revenue, or US$867k). Market cap is less than US$10m (CA$11.0m market cap, or US$8.05m).New Risk • May 29New major risk - Revenue and earnings growthEarnings have declined by 4.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$444k). Earnings have declined by 4.1% per year over the past 5 years. Revenue is less than US$1m (CA$1.0m revenue, or US$758k). Market cap is less than US$10m (CA$11.0m market cap, or US$7.99m).Reported Earnings • May 23First quarter 2025 earnings released: CA$0.004 loss per share (vs CA$0.012 loss in 1Q 2024)First quarter 2025 results: CA$0.004 loss per share (improved from CA$0.012 loss in 1Q 2024). Revenue: CA$275.5k (up 107% from 1Q 2024). Net loss: CA$188.5k (loss narrowed 63% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.공시 • Mar 11Frequency Exchange Corp. announced that it expects to receive CAD 0.5 million in fundingFrequency Exchange Corp. announced a private placement of up to 2,000,000 units at a price of CAD 0.25 per unit for gross proceeds of CAD 500,000 on March 10, 2025. Each Unit is comprised of one common share and one common share purchase warrant having an exercise price of CAD 0.40 per Warrant and a term of 24 months from the date of closing f the Private Placement. Finders’ fees of up to 6% cash and 6% finders’ warrants, having the same terms as the Warrants, may be paid if applicable in respect of the private placement closing. The Private Placement is subject to TSX Venture Exchange approval and all securities issued will be subject to a four-month hold period.Board Change • Feb 28High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. Chairman, President & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.New Risk • Nov 27New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$834k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$834k free cash flow). Shares are highly illiquid. Negative equity (-CA$325k). Earnings have declined by 8.1% per year over the past 5 years. Revenue is less than US$1m (CA$880k revenue, or US$627k). Market cap is less than US$10m (CA$13.7m market cap, or US$9.79m). Minor Risk Shareholders have been diluted in the past year (14% increase in shares outstanding).Reported Earnings • Nov 27Third quarter 2024 earnings released: CA$0.005 loss per share (vs CA$0.009 loss in 3Q 2023)Third quarter 2024 results: CA$0.005 loss per share (improved from CA$0.009 loss in 3Q 2023). Revenue: CA$221.7k (up 39% from 3Q 2023). Net loss: CA$223.7k (loss narrowed 37% from 3Q 2023).공시 • Nov 22Cam Neely Joins Frequency Exchange Advisory BoardFrequency Exchange Corp. announce former NHL star, Hockey Hall of Fame Inductee and President of the Boston Bruins Cam Neely will be joining its Advisory Board, to play a strategic role as the Company enters its next phase of growth. Mr. Neely was a power forward for the Vancouver Canucks and Boston Bruins from 1983-96. He was inducted into the Hockey Hall of Fame in 2005 and was appointed Vice President of the Boston Bruins in 2007. In 2010 he assumed his current role as President of the Bruins. Mr. Neely is also President of the Cam Neely Foundation, a non-profit organization comprised of the Neely Cancer Fund, which raises money in support of cancer research and treatment, and Neely House, an organization providing accommodation, community, and support to cancer patients and their families during treatment. He also sat on the Board of Directors of Whistler Blackcomb Holdings Inc., the holding company for Whistler Blackcomb Ski Resort, before it was acquired by Vail Resorts Inc. in 2016.공시 • Sep 19Frequency Exchange Corp. announced that it has received CAD 0.763077 million in fundingOn September 18, 2024, Frequency Exchange Corp. closed the transaction. The company issued an additional1,866,667 units at a price of CAD 0.15 per unit for gross proceeds of up to CAD 280,000, bringing the total private placement to 5,087,178 units for aggregated proceeds of CAD 763,077 when combined with the two previous closings subject to final approval from the TSX Venture Exchange. In connection with the closing of the final tranche, the company issued 60,000 finder's warrants having the same terms as the warrants and paid a cash commission of CAD 9,000 to Canaccord Genuity Corp.공시 • Sep 17Frequency Exchange Corp., Annual General Meeting, Nov 13, 2024Frequency Exchange Corp., Annual General Meeting, Nov 13, 2024. Location: british columbia, vancouver CanadaNew Risk • Aug 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$711k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$711k free cash flow). Shares are highly illiquid. Negative equity (-CA$551k). Earnings have declined by 13% per year over the past 5 years. Revenue is less than US$1m (CA$817k revenue, or US$607k). Market cap is less than US$10m (CA$6.37m market cap, or US$4.72m). Minor Risk Shareholders have been diluted in the past year (9.5% increase in shares outstanding).Reported Earnings • Aug 31Second quarter 2024 earnings released: CA$0.005 loss per share (vs CA$0.009 loss in 2Q 2023)Second quarter 2024 results: CA$0.005 loss per share (improved from CA$0.009 loss in 2Q 2023). Revenue: CA$264.8k (up 37% from 2Q 2023). Net loss: CA$223.4k (loss narrowed 32% from 2Q 2023).Reported Earnings • Jun 04First quarter 2024 earnings released: CA$0.012 loss per share (vs CA$0.011 loss in 1Q 2023)First quarter 2024 results: CA$0.012 loss per share (further deteriorated from CA$0.011 loss in 1Q 2023). Revenue: CA$133.3k (down 39% from 1Q 2023). Net loss: CA$505.1k (loss widened 26% from 1Q 2023).Reported Earnings • Apr 25Full year 2023 earnings released: CA$0.037 loss per share (vs CA$0.14 loss in FY 2022)Full year 2023 results: CA$0.037 loss per share (improved from CA$0.14 loss in FY 2022). Revenue: CA$829.7k (up 19% from FY 2022). Net loss: CA$1.44m (loss narrowed 71% from FY 2022).공시 • Apr 18Frequency Exchange Corp. announced that it expects to receive CAD 0.5 million in fundingFrequency Exchange Corp. announced a private placement of up to 3,333,333 units at a price of CAD 0.15 per unit for gross proceeds of up to CAD 499,999.95 on April 17, 2024. Each Unit is comprised of one common share and one common share purchase warrant having an exercise price of CAD 0.25 per warrant and a term of 24 months from the date of closing of the Private Placement. In the event that, during the 24 month period following the closing date, the volume-weighted average trading price of the common shares on the TSX Ventures Exchange is at least CAD 0.40 per Common Share for any period of 10 consecutive trading days, the company may, at its sole option, accelerate the expiry date of warrants to the date that is not less than 21 days following the date upon which notice of the accelerated expiry date is provided by the company by way of news release. Finders' fees of up to 6% cash and 6% finders' warrants, having the same terms as the warrants, may be paid if applicable in respect of the private placement closing. The private placement is subject to TSX Venture Exchange approval and all securities issued will be subject to a four-month hold period.Reported Earnings • Dec 01Third quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.013 loss in 3Q 2022)Third quarter 2023 results: CA$0.01 loss per share (improved from CA$0.013 loss in 3Q 2022). Revenue: CA$159.1k (up 29% from 3Q 2022). Net loss: CA$354.3k (loss narrowed 23% from 3Q 2022).공시 • Nov 21Frequency Exchange Corp.'s Subsidiary Fremedica Technologies Inc. Announces Appointment to Advisory BoardFrequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc., has increased its team by adding two key roles. As Corporate Ambassador and Director of Business Development, Allison Butenschon will oversee development of opportunities now opened with expansion of its rights. Alexandra Moresco becomes its PR and Social Media director responsible for growing NIKKI awareness and demand across all of its communications platforms. Allison Butenschon, Director of Business Development: Allison Butenschon is an entrepreneur with a diverse and colourful career. Her health and wellness journey began with a personal battle against Lyme disease contracted at age 18. This challenging experience shaped her life and inspired her to help others facing similar emotional and physical devastation. Despite her disease, Allison has made significant contributions as a clothing, interior and lifestyle designer. She has also been instrumental in commercial and residential building development, demonstrating her business skills as an innovative thinker and leader. With her unique blend of expertise in alternative health, design, and business development, Allison continues to inspire and empower individuals to overcome adversity and pursue their dreams. Alexandra Moresco, Public Relations and Social Media Director: When Alexandra was stricken with Lyme disease, she shifted the focus of her entertainment and talent relations company to helping other Lyme sufferers and creating partnerships to find a cure. With degrees in public relations, advertising and journalism, she adds her personal experience living with chronic disease to build long-lasting relations with both media and patient communities. Alexandra works with companies including Nike, Complex Magazine and Facebook Watch-now, boasting a client roster of top tier medical, healthcare and wellness clients. She has raised hundreds of thousands of dollars for tick-borne illness research and over the past year has secured over 250 prominent placements with media readership equating to a billion viewers.공시 • Nov 14FREmedica Technologies Inc. Announces Advisory Board AppointmentsFrequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc. (FREmedica), has increased its team with the addition of Linda Fontana (Business Development), Andy Parkins (Operations & Systems Development) and Dale Maclean (Public Market Strategies.) These new appointments bring further vision and expertise to the company's advisory resource. Linda Fontana- Corporate Consultant and Coach: Since 1988, Linda's career path has taken her to a wide array of occupations in Canada and the United States. She has been a business owner, consultant, speaker and business training development and recruitment specialist. Married with a daughter, she lost her 38 year-old husband Brian to ALS in 2003. Linda became inspired to help those with ALS lead better and more meaningful lives and ultimately find a cure. As a passionate wellness advocate, Linda is a welcome addition to the FREmedica advisory board and a worthy representative of its corporate and personal values. Dale R. MacLean, MBA-Business Management Leader: Dale is a strategic, innovative and results-driven leader with a track record of optimizing shareholder value. As CEO of Tree Island Steel he guided a 78% growth from 132 million to 235 million. Dale understands and works effectively with regulators, boards, Investment communities, elected Officials, community leaders, First Nations Leaders, labour leaders and the Media. He brings proven expertise in growing and running medium-large, complex, international businesses. Dale's experience in commercial and operational transactions and business management throughout North America, Asia and the Pacific Rim will factor in establishing and growing the Fremedica global market. Andy Parkins-Entrepreneur and technology innovator: Andy is the Founder and CEO of Six Factor, Google's leading cloud partner in Western Canada. Over more than 25 years of developing technology solutions for business, he has led an array of global institutions in transforming and evolving their operations into world-class, client-centric product and service providers. Andy has held prominent leadership roles at the Insurance Corporation of British Columbia, Deloitte, the Monitise Group, the Royal Bank of Scotland, Qantas and Computer Visionwhere. He speaks at conferences on how businesses are delivering the leaders of tomorrow, and how converging technologies are transforming its world.New Risk • Sep 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 13% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$385k). Earnings have declined by 42% per year over the past 5 years. Revenue is less than US$1m (CA$744k revenue, or US$545k). Market cap is less than US$10m (CA$3.11m market cap, or US$2.28m). Minor Risk Shareholders have been diluted in the past year (13% increase in shares outstanding).Reported Earnings • Sep 01Second quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.014 loss in 2Q 2022)Second quarter 2023 results: CA$0.01 loss per share (improved from CA$0.014 loss in 2Q 2022). Revenue: CA$193.0k (up 43% from 2Q 2022). Net loss: CA$328.8k (loss narrowed 35% from 2Q 2022).공시 • Aug 07Frequency Exchange Corp. announced that it expects to receive CAD 0.5 million in fundingFrequency Exchange Corp. announced a private placement of up to 5 million units at a price of CAD 0.10 per unit for gross proceeds of up to CAD 500,000 on August 5, 2023. Each unit consists of one common share and one common share purchase warrant having an exercise price of CAD 0.15 per warrant and a term of 24 months from the date of closing of the transaction. During the 24-month period following the closing date, the volume-weighted average trading price of the common shares on the TSX Ventures Exchange is at least CAD 0.50 per common share for any period of 10 consecutive trading days, the company may, at its sole option, accelerate the expiry date of warrants to the date that is not less than 21 days following the date upon which notice of the accelerated expiry date is provided by the company. The transaction is subject to TSX Venture Exchange approval and all securities issued will be subject to a four-month hold period.Reported Earnings • Jun 03First quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.10 loss in 1Q 2022)First quarter 2023 results: CA$0.01 loss per share (improved from CA$0.10 loss in 1Q 2022). Revenue: CA$217.4k (down 5.6% from 1Q 2022). Net loss: CA$399.8k (loss narrowed 88% from 1Q 2022).공시 • May 27Frequency Exchange Corp., Annual General Meeting, Jul 25, 2023Frequency Exchange Corp., Annual General Meeting, Jul 25, 2023.Reported Earnings • Apr 29Full year 2022 earnings released: CA$0.14 loss per share (vs CA$0.076 loss in FY 2021)Full year 2022 results: CA$0.14 loss per share (further deteriorated from CA$0.076 loss in FY 2021). Revenue: CA$699.1k (down 29% from FY 2021). Net loss: CA$4.86m (loss widened CA$4.10m from FY 2021).Board Change • Jan 25Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Jan 21FREmedica Technologies Inc. Appoints Jeff Barnes as Chief Marketing OfficerFrequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc. has extended their relationship with Jeff Barnes, founding partner of the Angel Investor Network to continue as Chief Marketing Officer to launch NIKKI, a wearable frequency delivery system that supports recovery from wellness and performance issues during sleep. In addition to his long history in marketing, Jeff also worked as a nuclear power plant operator on a submarine in the U.S. Navy, acquiring a unique perspective on new technologies and a strong under standing of how they work. As a two-time best-selling author, he has helped businesses generate over $100 million in revenue and startups raise over $1 billion in funding during the course of his career.Reported Earnings • Dec 01Third quarter 2022 earnings released: CA$0.013 loss per share (vs CA$0.009 loss in 3Q 2021)Third quarter 2022 results: CA$0.013 loss per share (further deteriorated from CA$0.009 loss in 3Q 2021). Revenue: CA$123.1k (down 42% from 3Q 2021). Net loss: CA$457.6k (loss widened 181% from 3Q 2021).Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Nov 05Fremedica Technologies Inc. Launches Nikki, A Frequency Delivery System That You WearFREmedica Technologies Inc. has launched NIKKI, a Frequency Delivery System that supports recovery from wellness and performance issues while you sleep, into Canada USA and Europe. Bioenergetics-based NIKKI emits frequencies that help restore cellular function within the body's network of 37 trillion cells. NIKKI works at night to overcome physical and emotional trauma experienced during the day that may cause fatigue, pain, stress which will all affect your sleep.공시 • Oct 29FREmedica Technologies Inc. Announces Launch Date for NIKKIFREmedica Technologies Inc. announces an October 31st launch date for NIKKI, a Frequency Deliver System that supports recovery from wellness and performance issues while one sleeps. Bioenergetics-based NIKKI emits frequencies that help restore cellular function within the body's network of 37 trillion cells. NIKKI works at night to overcome physical and emotional trauma experienced during the day. In daytime mode, NIKKI offers a range of frequencies chosen to complement the day's issues and activities; from a stressful meeting to running a half-marathon. Reservations for an initial run of 5,000 NIKKI devices are being taken at www.WeAreNikki.com, with delivery scheduled for November. A $250 NIKKI early-adopter pre-release includes the NIKKI Gold package, with the device, lifetime access to the Night- Time frequency package and a one-year subscription to the Energy Boost, Stress and Anxiety, Pain Relief and Travel frequency programs at a savings of $120. Special offer ends December 1, 2022, when retail pricing goes into effect with a $10 monthly subscription for the additional frequencies.공시 • Oct 28Fremedica Launches Night-Time Wearable That Improves Cellular Function for Better Sleep, Less Pain, and More EnergyFrequency Exchange Corp. announce that its wholly-owned subsidiary, FREmedica Technologies Inc. ("FREmedica"), announces an October 31st launch date for NIKKI, a Frequency Deliver System that supports recovery from wellness and performance issues while sleep. Bioenergetics-based NIKKI emits frequencies that help restore cellular function within the body's network of37 trillion cells.NIKKI works at night to overcome physical and emotional trauma experienced during the day. In daytime mode, NIKKI offers a range of frequencies chosen to complement the day's issues and activities; from a stressful meeting to running a half-marathon. A $250 NIKKI early-adopter pre-release includes the NIKKI Gold package, with the device, lifetime access to the Night-Time frequency package and a one-year subscription to the Energy Boost, Stress and Anxiety, Pain Relief and Travel frequency programs at a savings of $120.Board Change • Oct 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Sep 15FREmedica Technologies Inc. Announces Significant Proof of Concept Trial ResultsFrequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc., has completed a third-party ‘Quality of Life' Proof of Concept trial. The clinically validated, eight-week study demonstrated a significant improvement in 73% of participants, and some improvement in an additional 17% of participants using NIKKI and the Night-Time frequency package. NIKKI is a first-of-its-kind frequency emitter that delivers frequency packages into the body designed for wellness and performance enhancement.공시 • Sep 13+ 1 more updateFrequency Exchange Corp. Announces Executive ChangesFrequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc. (FREmedica), has appointed Nicole Sullivan as President of FREmedica effective September 6th, 2022. Ms. Sullivan has been with FREmedica since 2017, most recently serving the company as Vice President. She came to FREmedica with a wealth of experience in a variety of roles, as well as having flexed her entrepreneurial muscle in the completmentary health arena formulating and marketing her own aromatherapy blends over a 14 year period. Frequency Exchange also announced the resignation of Ms. Mary-Lynn Bellamy-Willms from the Board of Directors and as President of the Company. Frequency Exchange announced that it has appointed Nicole Sullivan to the Board of Directors of the Company effective September 8, 2022.Reported Earnings • Sep 03Second quarter 2022 earnings released: CA$0.014 loss per share (vs CA$0.016 loss in 2Q 2021)Second quarter 2022 results: CA$0.014 loss per share. Revenue: CA$134.8k (down 36% from 2Q 2021). Net loss: CA$508.9k (loss widened 212% from 2Q 2021).Board Change • Apr 27Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Chairman & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Mar 28Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Chairman & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Feb 09Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Chairman & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.주주 수익률FREQCA Medical EquipmentCA 시장7D0%1.0%-1.0%1Y4.0%-18.3%31.1%전체 주주 수익률 보기수익률 대 산업: FREQ은 지난 1년 동안 -18.3%의 수익을 기록한 Canadian Medical Equipment 산업보다 더 좋은 성과를 냈습니다.수익률 대 시장: FREQ은 지난 1년 동안 31.1%를 기록한 Canadian 시장보다 저조한 성과를 냈습니다.주가 변동성Is FREQ's price volatile compared to industry and market?FREQ volatilityFREQ Average Weekly Movement24.7%Medical Equipment Industry Average Movement15.6%Market Average Movement9.9%10% most volatile stocks in CA Market17.1%10% least volatile stocks in CA Market3.8%안정적인 주가: FREQ의 주가는 지난 3개월 동안 Canadian 시장보다 변동성이 컸습니다.시간에 따른 변동성: FREQ의 주간 변동성은 지난 1년간 31%에서 25%로 감소했지만 여전히 Canadian 종목의 상위 75%보다 높습니다.회사 소개설립직원 수CEO웹사이트n/an/aStephen Davisfrequencyexchangecorp.com는 건강 및 웰빙 시장을 위한 웨어러블 주파수 전달 시스템의 개발 및 상용화에 주력하는 회사입니다. 이 회사는 캐나다 밴쿠버에 본사를 두고 있습니다. 는 웨이브포스 일렉트로닉스(Waveforce Electronics Inc.)의 자회사입니다.더 보기Frequency Exchange Corp. 기초 지표 요약Frequency Exchange의 순이익과 매출은 시가총액과 어떻게 비교됩니까?FREQ 기초 통계시가총액CA$15.33m순이익 (TTM)-CA$1.90m매출 (TTM)CA$745.08k20.6x주가매출비율(P/S)-8.1x주가수익비율(P/E)FREQ는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표FREQ 손익계산서 (TTM)매출CA$745.08k매출원가CA$280.51k총이익CA$464.57k기타 비용CA$2.36m순이익-CA$1.90m최근 보고된 실적Mar 31, 2026다음 실적 발표일해당 없음주당순이익(EPS)-0.032총이익률62.35%순이익률-254.90%부채/자본 비율149.5%FREQ의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/22 16:58종가2026/06/19 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Frequency Exchange Corp.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
New Risk • Jun 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: CA$13.6m (US$9.56m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.4m free cash flow). Share price has been highly volatile over the past 3 months (25% average weekly change). Revenue is less than US$1m (CA$745k revenue, or US$526k). Market cap is less than US$10m (CA$13.6m market cap, or US$9.56m). Minor Risk Shareholders have been diluted in the past year (22% increase in shares outstanding).
New Risk • Apr 26New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.2m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.2m free cash flow). Share price has been highly volatile over the past 3 months (30% average weekly change). Revenue is less than US$1m (CA$886k revenue, or US$649k). Minor Risks Shareholders have been diluted in the past year (22% increase in shares outstanding). Market cap is less than US$100m (CA$16.3m market cap, or US$11.9m).
공시 • Apr 21Frequency Exchange Corp., Annual General Meeting, Jun 16, 2026Frequency Exchange Corp., Annual General Meeting, Jun 16, 2026. Location: british columbia, vancouver Canada
New Risk • Feb 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: CA$11.6m (US$8.56m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Revenue is less than US$1m (CA$1.1m revenue, or US$828k). Market cap is less than US$10m (CA$11.6m market cap, or US$8.56m). Minor Risk Shareholders have been diluted in the past year (23% increase in shares outstanding).
Board Change • Jan 02High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. Chairman, President & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Dec 20Frequency Exchange Corp. Announces the Appointment of Sammy Chow to Its Advisory BoardFrequency Exchange Corp. announced the appointment of Sammy Chow to its Advisory Board. Sammy Chow brings more than two decades of leadership experience in finance, operations, corporate development, and strategy. He has held senior executive roles including Chief Financial Officer and Chief Operating Officer across sectors such as manufacturing, technology, and renewable energy. Mr. Chow has worked with both startups and global organizations, including Fortune 500 companies, across Asia, the United States, and Canada. He has led and supported initiatives involving capital investments, market entry, and strategic partnerships resulting in more than $1 billion in successful transactions. Sammy adds valuable capital markets and operational depth to leadership group. Sammy holds an MBA from the University of Ottawa, a Bachelor of Commerce from the University of British Columbia, and is a Chartered Financial Analyst (CFA).
New Risk • Jun 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: CA$13.6m (US$9.56m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.4m free cash flow). Share price has been highly volatile over the past 3 months (25% average weekly change). Revenue is less than US$1m (CA$745k revenue, or US$526k). Market cap is less than US$10m (CA$13.6m market cap, or US$9.56m). Minor Risk Shareholders have been diluted in the past year (22% increase in shares outstanding).
New Risk • Apr 26New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.2m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.2m free cash flow). Share price has been highly volatile over the past 3 months (30% average weekly change). Revenue is less than US$1m (CA$886k revenue, or US$649k). Minor Risks Shareholders have been diluted in the past year (22% increase in shares outstanding). Market cap is less than US$100m (CA$16.3m market cap, or US$11.9m).
공시 • Apr 21Frequency Exchange Corp., Annual General Meeting, Jun 16, 2026Frequency Exchange Corp., Annual General Meeting, Jun 16, 2026. Location: british columbia, vancouver Canada
New Risk • Feb 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: CA$11.6m (US$8.56m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Revenue is less than US$1m (CA$1.1m revenue, or US$828k). Market cap is less than US$10m (CA$11.6m market cap, or US$8.56m). Minor Risk Shareholders have been diluted in the past year (23% increase in shares outstanding).
Board Change • Jan 02High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. Chairman, President & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Dec 20Frequency Exchange Corp. Announces the Appointment of Sammy Chow to Its Advisory BoardFrequency Exchange Corp. announced the appointment of Sammy Chow to its Advisory Board. Sammy Chow brings more than two decades of leadership experience in finance, operations, corporate development, and strategy. He has held senior executive roles including Chief Financial Officer and Chief Operating Officer across sectors such as manufacturing, technology, and renewable energy. Mr. Chow has worked with both startups and global organizations, including Fortune 500 companies, across Asia, the United States, and Canada. He has led and supported initiatives involving capital investments, market entry, and strategic partnerships resulting in more than $1 billion in successful transactions. Sammy adds valuable capital markets and operational depth to leadership group. Sammy holds an MBA from the University of Ottawa, a Bachelor of Commerce from the University of British Columbia, and is a Chartered Financial Analyst (CFA).
공시 • Dec 18Frequency Exchange Corp. Announces the Appointment of Gail Edgell to Its Advisory BoardFrequency Exchange Corp. announced the appointment of Gail Edgell to its Advisory Board. Gail Edgell brings over 25 years of experience in the wellness industry, with leadership roles across corporate wellness, professional supplements, biotechnology startups, and integrative clinical consulting. She has held strategic positions focused on market development, practitioner engagement, and education-based commercialization, contributing to consistent revenue growth across several companies. Her career includes senior contributions at Designs for Health, where she helped scale practitioner channel sales from $360,000 to $1.5 million in under three years, and at Bio-Botanical Research, where she launched a practitioner partnership model that reached $1 million in annualized revenue within 90 days. Ms. Edgell has also supported business development efforts at Panaceutics Nutrition, a biotech startup, and has advised numerous integrative health clinics on operational growth and patient education strategies. Ms. Edgell is also a published author, founder of Inside Out Wellness, and a former nonprofit executive who led wellness-focused programs serving over 300 organizations and communities. She continues to collaborate with leading nutrition companies and healthcare educators to reimagine practitioner support experiences.
공시 • Dec 15Frequency Exchange Corp Appoints Michael Moe To Advisory BoardFrequency Exchange Corp. has appointed Michael Moe to its Advisory Board. Michael Moe is the Founder and CEO of GSV. He is also the co-founder of the ASU+GSV Summit, which Forbes referred to as the Davos of Education, and has contributed to expanding global interest in the digital learning and wellness sectors through GSV's various funds and partnerships. Mr. Moe previously served as Head of Global Growth Research at Merrill Lynch and was named to the Institutional Investor All-America Research Team. He also founded ThinkEquity Partners and has authored several books on entrepreneurship and impact-focused investing. Michael holds a BA in Political Science and Economics from the University of Minnesota and is a CFA charterholder.
Reported Earnings • Nov 21Third quarter 2025 earnings released: CA$0.016 loss per share (vs CA$0.005 loss in 3Q 2024)Third quarter 2025 results: CA$0.016 loss per share (further deteriorated from CA$0.005 loss in 3Q 2024). Revenue: CA$170.0k (down 23% from 3Q 2024). Net loss: CA$796.0k (loss widened 256% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.
공시 • Sep 25Frequency Exchange Corp. announced that it has received CAD 1.838034 million in fundingOn September 24, 2025, Frequency Exchange Corp. closed the transaction. The company issued an additional 3,418,031 units at a price of CAD 0.25 per unit for proceeds of CAD 854,507.75 in second and final tranche, bringing the total private placement to 7,352,133 units for aggregated proceeds of CAD 1,838,033.25 when combined with the first-tranche closing. Each unit consisted of one common share and one common share purchase warrant having an exercise price of CAD 0.40 per warrant and a term of 24 months from the date of issuance. The company issued 72,800 non-transferable finder warrants and paid a cash commission of CAD 18,200 to Canaccord Genuity Corp. The finder warrants are at an exercise price of CAD 0.40 per share for a period of 24 months from the date of issuance and are subject to the same acceleration clause as the warrants. All securities issued in connection with the second tranche of the private placement are subject to a statutory hold period expiring January 25, 2026.
New Risk • Sep 25New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 15% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CA$689k). Revenue is less than US$1m (CA$1.2m revenue, or US$845k). Minor Risks Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (CA$17.5m market cap, or US$12.6m).
New Risk • Aug 28New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 15% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$689k). Revenue is less than US$1m (CA$1.2m revenue, or US$852k). Minor Risks Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (CA$18.4m market cap, or US$13.3m).
Reported Earnings • Aug 26Second quarter 2025 earnings released: CA$0.003 loss per share (vs CA$0.005 loss in 2Q 2024)Second quarter 2025 results: CA$0.003 loss per share (improved from CA$0.005 loss in 2Q 2024). Revenue: CA$250.2k (down 5.5% from 2Q 2024). Net loss: CA$122.0k (loss narrowed 45% from 2Q 2024). Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.
공시 • Jul 22Frequency Exchange Corp. announced that it expects to receive CAD 1.5 million in fundingFrequency Exchange Corp. announced a private placement to issue 6,000,000 units at an issue price of CAD 0.25 per unit for gross proceeds of CAD 1,500,000 on July 21, 2025. Each unit is comprised of one common share and one common share purchase warrant having an exercise price of CAD 0.40 per warrant and a term of 24 months from the date of closing of the private placement. Finders’ fees of up to 8% cash and 8% finders’ warrants, having the same terms as the warrants, may be paid if applicable in respect of the private placement closing. The private placement is subject to TSX Venture Exchange approval, and all securities issued will be subject to a four-month hold period.
Board Change • Jun 04High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. Chairman, President & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
New Risk • May 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$724k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$724k free cash flow). Shares are highly illiquid. Negative equity (-CA$623k). Revenue is less than US$1m (CA$1.2m revenue, or US$867k). Market cap is less than US$10m (CA$11.0m market cap, or US$8.05m).
New Risk • May 29New major risk - Revenue and earnings growthEarnings have declined by 4.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$444k). Earnings have declined by 4.1% per year over the past 5 years. Revenue is less than US$1m (CA$1.0m revenue, or US$758k). Market cap is less than US$10m (CA$11.0m market cap, or US$7.99m).
Reported Earnings • May 23First quarter 2025 earnings released: CA$0.004 loss per share (vs CA$0.012 loss in 1Q 2024)First quarter 2025 results: CA$0.004 loss per share (improved from CA$0.012 loss in 1Q 2024). Revenue: CA$275.5k (up 107% from 1Q 2024). Net loss: CA$188.5k (loss narrowed 63% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.
공시 • Mar 11Frequency Exchange Corp. announced that it expects to receive CAD 0.5 million in fundingFrequency Exchange Corp. announced a private placement of up to 2,000,000 units at a price of CAD 0.25 per unit for gross proceeds of CAD 500,000 on March 10, 2025. Each Unit is comprised of one common share and one common share purchase warrant having an exercise price of CAD 0.40 per Warrant and a term of 24 months from the date of closing f the Private Placement. Finders’ fees of up to 6% cash and 6% finders’ warrants, having the same terms as the Warrants, may be paid if applicable in respect of the private placement closing. The Private Placement is subject to TSX Venture Exchange approval and all securities issued will be subject to a four-month hold period.
Board Change • Feb 28High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. Chairman, President & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
New Risk • Nov 27New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$834k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$834k free cash flow). Shares are highly illiquid. Negative equity (-CA$325k). Earnings have declined by 8.1% per year over the past 5 years. Revenue is less than US$1m (CA$880k revenue, or US$627k). Market cap is less than US$10m (CA$13.7m market cap, or US$9.79m). Minor Risk Shareholders have been diluted in the past year (14% increase in shares outstanding).
Reported Earnings • Nov 27Third quarter 2024 earnings released: CA$0.005 loss per share (vs CA$0.009 loss in 3Q 2023)Third quarter 2024 results: CA$0.005 loss per share (improved from CA$0.009 loss in 3Q 2023). Revenue: CA$221.7k (up 39% from 3Q 2023). Net loss: CA$223.7k (loss narrowed 37% from 3Q 2023).
공시 • Nov 22Cam Neely Joins Frequency Exchange Advisory BoardFrequency Exchange Corp. announce former NHL star, Hockey Hall of Fame Inductee and President of the Boston Bruins Cam Neely will be joining its Advisory Board, to play a strategic role as the Company enters its next phase of growth. Mr. Neely was a power forward for the Vancouver Canucks and Boston Bruins from 1983-96. He was inducted into the Hockey Hall of Fame in 2005 and was appointed Vice President of the Boston Bruins in 2007. In 2010 he assumed his current role as President of the Bruins. Mr. Neely is also President of the Cam Neely Foundation, a non-profit organization comprised of the Neely Cancer Fund, which raises money in support of cancer research and treatment, and Neely House, an organization providing accommodation, community, and support to cancer patients and their families during treatment. He also sat on the Board of Directors of Whistler Blackcomb Holdings Inc., the holding company for Whistler Blackcomb Ski Resort, before it was acquired by Vail Resorts Inc. in 2016.
공시 • Sep 19Frequency Exchange Corp. announced that it has received CAD 0.763077 million in fundingOn September 18, 2024, Frequency Exchange Corp. closed the transaction. The company issued an additional1,866,667 units at a price of CAD 0.15 per unit for gross proceeds of up to CAD 280,000, bringing the total private placement to 5,087,178 units for aggregated proceeds of CAD 763,077 when combined with the two previous closings subject to final approval from the TSX Venture Exchange. In connection with the closing of the final tranche, the company issued 60,000 finder's warrants having the same terms as the warrants and paid a cash commission of CAD 9,000 to Canaccord Genuity Corp.
공시 • Sep 17Frequency Exchange Corp., Annual General Meeting, Nov 13, 2024Frequency Exchange Corp., Annual General Meeting, Nov 13, 2024. Location: british columbia, vancouver Canada
New Risk • Aug 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$711k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$711k free cash flow). Shares are highly illiquid. Negative equity (-CA$551k). Earnings have declined by 13% per year over the past 5 years. Revenue is less than US$1m (CA$817k revenue, or US$607k). Market cap is less than US$10m (CA$6.37m market cap, or US$4.72m). Minor Risk Shareholders have been diluted in the past year (9.5% increase in shares outstanding).
Reported Earnings • Aug 31Second quarter 2024 earnings released: CA$0.005 loss per share (vs CA$0.009 loss in 2Q 2023)Second quarter 2024 results: CA$0.005 loss per share (improved from CA$0.009 loss in 2Q 2023). Revenue: CA$264.8k (up 37% from 2Q 2023). Net loss: CA$223.4k (loss narrowed 32% from 2Q 2023).
Reported Earnings • Jun 04First quarter 2024 earnings released: CA$0.012 loss per share (vs CA$0.011 loss in 1Q 2023)First quarter 2024 results: CA$0.012 loss per share (further deteriorated from CA$0.011 loss in 1Q 2023). Revenue: CA$133.3k (down 39% from 1Q 2023). Net loss: CA$505.1k (loss widened 26% from 1Q 2023).
Reported Earnings • Apr 25Full year 2023 earnings released: CA$0.037 loss per share (vs CA$0.14 loss in FY 2022)Full year 2023 results: CA$0.037 loss per share (improved from CA$0.14 loss in FY 2022). Revenue: CA$829.7k (up 19% from FY 2022). Net loss: CA$1.44m (loss narrowed 71% from FY 2022).
공시 • Apr 18Frequency Exchange Corp. announced that it expects to receive CAD 0.5 million in fundingFrequency Exchange Corp. announced a private placement of up to 3,333,333 units at a price of CAD 0.15 per unit for gross proceeds of up to CAD 499,999.95 on April 17, 2024. Each Unit is comprised of one common share and one common share purchase warrant having an exercise price of CAD 0.25 per warrant and a term of 24 months from the date of closing of the Private Placement. In the event that, during the 24 month period following the closing date, the volume-weighted average trading price of the common shares on the TSX Ventures Exchange is at least CAD 0.40 per Common Share for any period of 10 consecutive trading days, the company may, at its sole option, accelerate the expiry date of warrants to the date that is not less than 21 days following the date upon which notice of the accelerated expiry date is provided by the company by way of news release. Finders' fees of up to 6% cash and 6% finders' warrants, having the same terms as the warrants, may be paid if applicable in respect of the private placement closing. The private placement is subject to TSX Venture Exchange approval and all securities issued will be subject to a four-month hold period.
Reported Earnings • Dec 01Third quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.013 loss in 3Q 2022)Third quarter 2023 results: CA$0.01 loss per share (improved from CA$0.013 loss in 3Q 2022). Revenue: CA$159.1k (up 29% from 3Q 2022). Net loss: CA$354.3k (loss narrowed 23% from 3Q 2022).
공시 • Nov 21Frequency Exchange Corp.'s Subsidiary Fremedica Technologies Inc. Announces Appointment to Advisory BoardFrequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc., has increased its team by adding two key roles. As Corporate Ambassador and Director of Business Development, Allison Butenschon will oversee development of opportunities now opened with expansion of its rights. Alexandra Moresco becomes its PR and Social Media director responsible for growing NIKKI awareness and demand across all of its communications platforms. Allison Butenschon, Director of Business Development: Allison Butenschon is an entrepreneur with a diverse and colourful career. Her health and wellness journey began with a personal battle against Lyme disease contracted at age 18. This challenging experience shaped her life and inspired her to help others facing similar emotional and physical devastation. Despite her disease, Allison has made significant contributions as a clothing, interior and lifestyle designer. She has also been instrumental in commercial and residential building development, demonstrating her business skills as an innovative thinker and leader. With her unique blend of expertise in alternative health, design, and business development, Allison continues to inspire and empower individuals to overcome adversity and pursue their dreams. Alexandra Moresco, Public Relations and Social Media Director: When Alexandra was stricken with Lyme disease, she shifted the focus of her entertainment and talent relations company to helping other Lyme sufferers and creating partnerships to find a cure. With degrees in public relations, advertising and journalism, she adds her personal experience living with chronic disease to build long-lasting relations with both media and patient communities. Alexandra works with companies including Nike, Complex Magazine and Facebook Watch-now, boasting a client roster of top tier medical, healthcare and wellness clients. She has raised hundreds of thousands of dollars for tick-borne illness research and over the past year has secured over 250 prominent placements with media readership equating to a billion viewers.
공시 • Nov 14FREmedica Technologies Inc. Announces Advisory Board AppointmentsFrequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc. (FREmedica), has increased its team with the addition of Linda Fontana (Business Development), Andy Parkins (Operations & Systems Development) and Dale Maclean (Public Market Strategies.) These new appointments bring further vision and expertise to the company's advisory resource. Linda Fontana- Corporate Consultant and Coach: Since 1988, Linda's career path has taken her to a wide array of occupations in Canada and the United States. She has been a business owner, consultant, speaker and business training development and recruitment specialist. Married with a daughter, she lost her 38 year-old husband Brian to ALS in 2003. Linda became inspired to help those with ALS lead better and more meaningful lives and ultimately find a cure. As a passionate wellness advocate, Linda is a welcome addition to the FREmedica advisory board and a worthy representative of its corporate and personal values. Dale R. MacLean, MBA-Business Management Leader: Dale is a strategic, innovative and results-driven leader with a track record of optimizing shareholder value. As CEO of Tree Island Steel he guided a 78% growth from 132 million to 235 million. Dale understands and works effectively with regulators, boards, Investment communities, elected Officials, community leaders, First Nations Leaders, labour leaders and the Media. He brings proven expertise in growing and running medium-large, complex, international businesses. Dale's experience in commercial and operational transactions and business management throughout North America, Asia and the Pacific Rim will factor in establishing and growing the Fremedica global market. Andy Parkins-Entrepreneur and technology innovator: Andy is the Founder and CEO of Six Factor, Google's leading cloud partner in Western Canada. Over more than 25 years of developing technology solutions for business, he has led an array of global institutions in transforming and evolving their operations into world-class, client-centric product and service providers. Andy has held prominent leadership roles at the Insurance Corporation of British Columbia, Deloitte, the Monitise Group, the Royal Bank of Scotland, Qantas and Computer Visionwhere. He speaks at conferences on how businesses are delivering the leaders of tomorrow, and how converging technologies are transforming its world.
New Risk • Sep 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 13% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$385k). Earnings have declined by 42% per year over the past 5 years. Revenue is less than US$1m (CA$744k revenue, or US$545k). Market cap is less than US$10m (CA$3.11m market cap, or US$2.28m). Minor Risk Shareholders have been diluted in the past year (13% increase in shares outstanding).
Reported Earnings • Sep 01Second quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.014 loss in 2Q 2022)Second quarter 2023 results: CA$0.01 loss per share (improved from CA$0.014 loss in 2Q 2022). Revenue: CA$193.0k (up 43% from 2Q 2022). Net loss: CA$328.8k (loss narrowed 35% from 2Q 2022).
공시 • Aug 07Frequency Exchange Corp. announced that it expects to receive CAD 0.5 million in fundingFrequency Exchange Corp. announced a private placement of up to 5 million units at a price of CAD 0.10 per unit for gross proceeds of up to CAD 500,000 on August 5, 2023. Each unit consists of one common share and one common share purchase warrant having an exercise price of CAD 0.15 per warrant and a term of 24 months from the date of closing of the transaction. During the 24-month period following the closing date, the volume-weighted average trading price of the common shares on the TSX Ventures Exchange is at least CAD 0.50 per common share for any period of 10 consecutive trading days, the company may, at its sole option, accelerate the expiry date of warrants to the date that is not less than 21 days following the date upon which notice of the accelerated expiry date is provided by the company. The transaction is subject to TSX Venture Exchange approval and all securities issued will be subject to a four-month hold period.
Reported Earnings • Jun 03First quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.10 loss in 1Q 2022)First quarter 2023 results: CA$0.01 loss per share (improved from CA$0.10 loss in 1Q 2022). Revenue: CA$217.4k (down 5.6% from 1Q 2022). Net loss: CA$399.8k (loss narrowed 88% from 1Q 2022).
공시 • May 27Frequency Exchange Corp., Annual General Meeting, Jul 25, 2023Frequency Exchange Corp., Annual General Meeting, Jul 25, 2023.
Reported Earnings • Apr 29Full year 2022 earnings released: CA$0.14 loss per share (vs CA$0.076 loss in FY 2021)Full year 2022 results: CA$0.14 loss per share (further deteriorated from CA$0.076 loss in FY 2021). Revenue: CA$699.1k (down 29% from FY 2021). Net loss: CA$4.86m (loss widened CA$4.10m from FY 2021).
Board Change • Jan 25Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Jan 21FREmedica Technologies Inc. Appoints Jeff Barnes as Chief Marketing OfficerFrequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc. has extended their relationship with Jeff Barnes, founding partner of the Angel Investor Network to continue as Chief Marketing Officer to launch NIKKI, a wearable frequency delivery system that supports recovery from wellness and performance issues during sleep. In addition to his long history in marketing, Jeff also worked as a nuclear power plant operator on a submarine in the U.S. Navy, acquiring a unique perspective on new technologies and a strong under standing of how they work. As a two-time best-selling author, he has helped businesses generate over $100 million in revenue and startups raise over $1 billion in funding during the course of his career.
Reported Earnings • Dec 01Third quarter 2022 earnings released: CA$0.013 loss per share (vs CA$0.009 loss in 3Q 2021)Third quarter 2022 results: CA$0.013 loss per share (further deteriorated from CA$0.009 loss in 3Q 2021). Revenue: CA$123.1k (down 42% from 3Q 2021). Net loss: CA$457.6k (loss widened 181% from 3Q 2021).
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Nov 05Fremedica Technologies Inc. Launches Nikki, A Frequency Delivery System That You WearFREmedica Technologies Inc. has launched NIKKI, a Frequency Delivery System that supports recovery from wellness and performance issues while you sleep, into Canada USA and Europe. Bioenergetics-based NIKKI emits frequencies that help restore cellular function within the body's network of 37 trillion cells. NIKKI works at night to overcome physical and emotional trauma experienced during the day that may cause fatigue, pain, stress which will all affect your sleep.
공시 • Oct 29FREmedica Technologies Inc. Announces Launch Date for NIKKIFREmedica Technologies Inc. announces an October 31st launch date for NIKKI, a Frequency Deliver System that supports recovery from wellness and performance issues while one sleeps. Bioenergetics-based NIKKI emits frequencies that help restore cellular function within the body's network of 37 trillion cells. NIKKI works at night to overcome physical and emotional trauma experienced during the day. In daytime mode, NIKKI offers a range of frequencies chosen to complement the day's issues and activities; from a stressful meeting to running a half-marathon. Reservations for an initial run of 5,000 NIKKI devices are being taken at www.WeAreNikki.com, with delivery scheduled for November. A $250 NIKKI early-adopter pre-release includes the NIKKI Gold package, with the device, lifetime access to the Night- Time frequency package and a one-year subscription to the Energy Boost, Stress and Anxiety, Pain Relief and Travel frequency programs at a savings of $120. Special offer ends December 1, 2022, when retail pricing goes into effect with a $10 monthly subscription for the additional frequencies.
공시 • Oct 28Fremedica Launches Night-Time Wearable That Improves Cellular Function for Better Sleep, Less Pain, and More EnergyFrequency Exchange Corp. announce that its wholly-owned subsidiary, FREmedica Technologies Inc. ("FREmedica"), announces an October 31st launch date for NIKKI, a Frequency Deliver System that supports recovery from wellness and performance issues while sleep. Bioenergetics-based NIKKI emits frequencies that help restore cellular function within the body's network of37 trillion cells.NIKKI works at night to overcome physical and emotional trauma experienced during the day. In daytime mode, NIKKI offers a range of frequencies chosen to complement the day's issues and activities; from a stressful meeting to running a half-marathon. A $250 NIKKI early-adopter pre-release includes the NIKKI Gold package, with the device, lifetime access to the Night-Time frequency package and a one-year subscription to the Energy Boost, Stress and Anxiety, Pain Relief and Travel frequency programs at a savings of $120.
Board Change • Oct 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Sep 15FREmedica Technologies Inc. Announces Significant Proof of Concept Trial ResultsFrequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc., has completed a third-party ‘Quality of Life' Proof of Concept trial. The clinically validated, eight-week study demonstrated a significant improvement in 73% of participants, and some improvement in an additional 17% of participants using NIKKI and the Night-Time frequency package. NIKKI is a first-of-its-kind frequency emitter that delivers frequency packages into the body designed for wellness and performance enhancement.
공시 • Sep 13+ 1 more updateFrequency Exchange Corp. Announces Executive ChangesFrequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc. (FREmedica), has appointed Nicole Sullivan as President of FREmedica effective September 6th, 2022. Ms. Sullivan has been with FREmedica since 2017, most recently serving the company as Vice President. She came to FREmedica with a wealth of experience in a variety of roles, as well as having flexed her entrepreneurial muscle in the completmentary health arena formulating and marketing her own aromatherapy blends over a 14 year period. Frequency Exchange also announced the resignation of Ms. Mary-Lynn Bellamy-Willms from the Board of Directors and as President of the Company. Frequency Exchange announced that it has appointed Nicole Sullivan to the Board of Directors of the Company effective September 8, 2022.
Reported Earnings • Sep 03Second quarter 2022 earnings released: CA$0.014 loss per share (vs CA$0.016 loss in 2Q 2021)Second quarter 2022 results: CA$0.014 loss per share. Revenue: CA$134.8k (down 36% from 2Q 2021). Net loss: CA$508.9k (loss widened 212% from 2Q 2021).
Board Change • Apr 27Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Chairman & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Mar 28Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Chairman & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Feb 09Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Chairman & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
